HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study
HER-2基因改变作为接受FOLFIRI联合西妥昔单抗治疗的转移性结直肠癌患者的生物标志物:CAPRI-2 GOIM研究结果
期刊:
影响因子:
doi:10.1016/j.esmogo.2025.100295
Ciardiello, D; Boscolo Bielo, L; Napolitano, S; Martinelli, E; Troiani, T; Cioli, E; Latiano, T P; Maiello, E; Parente, P; Avallone, A; De Stefano, A; Bordonaro, R; Russo, A E; Lotesoriere, C; Vallarelli, S; Pisconti, S; Nisi, C; Tamburini, E; Viola, M G; Lonardi, S; Cremolini, C; Iacono, D; Tagliaferri, P; Pietrantonio, F; Tortora, G; Rosati, G; Zampino, M G; Curigliano, G; Febbraro, A; Normanno, N; De Vita, F; Fazio, N; Ciardiello, F; Martini, G